VIM-4 in a carbapenem-resistant strain of Pseudomonas aeruginosa isolated in Sweden

Antimicrob Agents Chemother. 2003 Sep;47(9):3034-5. doi: 10.1128/AAC.47.9.3034-3035.2003.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carbapenems / pharmacology*
  • Drug Resistance, Bacterial
  • Humans
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*
  • Pseudomonas aeruginosa / enzymology*
  • Sweden
  • beta-Lactamases / metabolism*

Substances

  • Carbapenems
  • beta-Lactamases
  • beta-lactamase bla(VIM-4), Pseudomonas aeruginosa